A novel approach to reduce catheter-related infection using sustained-release basic fibroblast growth factor for tissue regeneration in mice

Heart and Vessels

Volumn 22, Issue 4, 2007, Pages 261-267

  Hirose, Keiichi ^a   Marui, Akira ^b   Arai, Yoshio ^b   Nomura, Takamasa ^b   Kaneda, Kozo ^c   Kimura, Yu ^d   Ikeda, Tadashi ^b   Fujita, Masatoshi ^b   Mitsuyama, Masao ^b   Tabata, Yasuhiko ^d   Komeda, Masashi ^b  

^a SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Kindai University   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Catheter related bacterial invasion; Catheter related infection; Sustained release basic fibroblast growth factor; Tissue regeneration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COLLAGEN; DACRON; GELATIN;

ADJUVANT THERAPY; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CATHETER INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SIMULATION; DRUG DOSAGE FORM COMPARISON; FORCE; GRANULATION TISSUE; HYDROGEL; INOCULATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE; SUSTAINED RELEASE FORMULATION; TISSUE REGENERATION; TISSUE TRANSPLANTATION; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; CATHETERS, INDWELLING; COLLAGEN; COLONY COUNT, MICROBIAL; COLONY-FORMING UNITS ASSAY; DELAYED-ACTION PREPARATIONS; FIBROBLAST GROWTH FACTOR 2; GUIDED TISSUE REGENERATION; HYDROGEL; MALE; METHICILLIN RESISTANCE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; POLYETHYLENE TEREPHTHALATES; PROSTHESES AND IMPLANTS; STAPHYLOCOCCAL INFECTIONS; WOUND HEALING;

EID: 34547511281     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-006-0967-4     Document Type: Article

References (27)

1. DB Rafkin D Moscatelli 1989 Recent developments in the cell biology of basic fibroblast growth factor J Cell Biol 109 1-6 10.1083/jcb.109.1.1
2. A Yanagisawa-Miwa Y Uchida F Nakamura T Tomaru H Kido T Kamijo T Sugimoto K Kaji M Utsuyama C Kurashima 1992 Salvage of infracted myocardium by angiogenic action of basic fibroblast growth factor Science 257 1401-1403 1382313 10.1126/science.1382313 1:CAS:528:DyaK38Xmt1KqtL4%3D
3. M Noguchi K Eishi S Yamachika S Hazama 2004 Three cases of ischemic ulcer due to arteriosclerosis obliterans responding to basic fibroblast growth factor spray Heart Vessels 19 252-256 15372302
4. H Schliephake FW Newkam A Lohr D Hutmacher 1995 The use of basic fibroblast growth factor (bFGF) for enhancement of bone ingrowth into pyrolized bovine bone Int J Oral Maxillofac Surg 24 181-186 7608588 10.1016/S0901-5027(06)80098-6 1:STN:280:ByqA3s3nslc%3D
5. P Aebischer AN Salessiotis SR Winn 1989 Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across lone nerve gaps J Neurosci Res 23 282-289 2769793 10.1002/jnr.490230306 1:CAS:528:DyaL1MXkvFSkurw%3D
6. Y Tabata Y Ikada 1998 Protein release from gelatin matrices Adv Drug Deliv Rev 31 287-301 10837630 10.1016/S0169-409X(97)00125-7 1:CAS:528:DyaK1cXhvVSjsb4%3D
7. Y Tabata 2003 Tissue regeneration based on growth factor release Tissue Eng 9 Suppl 1 S5-S15 14511467 10.1089/10763270360696941 1:CAS:528:DC%2BD3sXnvF2lsLw%3D
8. A Iwakura Y Tabata M Miyao M Ozeki N Tamura A Ikai K Nishimura T Nakamura Y Shimizu M Fujita M Komeda 2000 Novel methods to enhance sternal healing after harvesting bilateral internal thoracic arteries with use of basic fibroblast growth factor Circulation 102 Suppl III III-307-III-311 1:STN:280:DC%2BD3M%2FlvFOqsw%3D%3D
9. Y Sakakibara K Nishimura K Tambara M Yamamoto F Lu Y Tabata M Komeda 2002 Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation J Thorac Cardiovasc Surg 124 50-56 12091808 10.1067/ mtc.2002.121293 1:CAS:528:DC%2BD38XlslKqtLw%3D
10. K Ueyama G Bing Y Tabata M Ozeki K Doi K Nishimura H Suma M Komeda 2004 Development of biologic coronary artery bypass grafting in a rabit model: Revival of a classic concept with modern biotechnology J Thorac Cardiovasc Surg 127 1608-1615 15173714 10.1016/j.jtcvs.2003.08.043
11. A Marui A Kanematsu Y Yamahara K Doi T Kushibiki M Yamamoto H Itoh T Ikeda Y Tabata M Komeda 2005 Simultaneous application of basic fibroblast growth factor and hepatocyte growth factor to enhance the blood vessels formation J Vasc Surg 41 82-90 15696049 10.1016/ j.jvs.2004.10.029
12. J Rello A Ochagavia E Sabanes M Roque D Mariscal E Reynaga J Valles 2000 Evaluation of outcome of intravenous catheter-related infection in critically ill patients Am J Respir Crit Care Med 162 1027-1030 10988125 1:STN:280:DC%2BD3cvotFajsQ%3D%3D
13. P Eggimann H Sax D Pittet 2004 Catheter-related infections Microbes Infect 6 1033-1042 15345236 10.1016/j.micinf.2004.05.018
14. RS Poston S Husain D Sorce E Stanford S Kusne M Wagener BP Griffith RL Kormos 2004 LVAD Bloodstream infections; therapeutic rationale for transplantation after LVAD infection J Heart Lung Transplant 22 914-921 10.1016/S1053-2498(02)00645-9
15. LA Mermel 2000 Prevention of intravascular catheter-related infections Ann Intern Med 132 391-402 10691590 1:STN:280:DC%2BD3c7ktlSlsA%3D%3D
16. G Ferretti M Mandala S Di Cosimo C Moro G Curiglano S Barni 2002 Catheter-related bloodstream infections, part I: Pathogenesis, diagnosis, and management Cancer Control 9 513-523 12514569
17. PN Dean F Dolbeare H Gratzner GC Rice JW Gray 1984 Cell-cycle analysis using a monoclonal antibody to BrdUrd Cell Tissue Kinet 17 427-436 6733753 1:CAS:528:DyaL2cXlt1KjurY%3D
18. HG Miltenburger G Sachse M Schliermann 1987 S-phase cell detection with a monoclonal antibody Dev Biol Stand 66 91-99 3556275 1:STN:280:BiiB3MbltFI%3D
19. LY Sun MS Evans J Hsieh J Panici A Bartke 2005 Increased neurigenesis in dentate gyrus of long-lived Ames dwarf mice Endocrinology 146 1138-1144 15564324 10.1210/en.2004-1115 1:CAS:528:DC%2BD2MXitlehsbo%3D
20. TM Bergamini RA Corpus Jr KR Brittian JC Peyton WG Cheadle 1994 The natural history of bacterial biofilm graft infection J Surg Res 56 393-396 8170137 10.1006/jsre.1994.1062 1:STN:280:ByuB38zoslw%3D
21. A Sitges-Serra J Linares J Garau 1985 Catheter sepsis: The clue is the hub Surgery 18 205-208
22. C Brun-Buisson F Doyon JP Sollet JF Cochard Y Cohen G Nitenberg 2004 Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: A randomized controlled trial Intensive Care Med 30 837-843 15060765 10.1007/ s00134-004-2221-9
23. ME Olson JC Nickel AE Khoury DW Morck R Cleeland JW Costerton 1989 Amidinocillin treatment of catheter associated bacteriuria in rabbits J Infect Dis 159 1065-1072 2656876 1:STN:280:BiaB2Mnns1Y%3D
24. K Olson RP Rennie J Hanson M Ryan J Gilpin M Falsetti T Heffner S Gaudet 2004 Evaluation of a no-dressing intervention for tunneled central venous catheter exit sites J Infus Nurs 27 37-44 14734986 10.1097/ 00129804-200401000-00006
25. K Harada W Grossman M Friedman ER Edelman PV Prasad CS Keighley WJ Manning FW Sellke M Simons 1994 Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts J Clin Invest 94 623-630 7518840 1:CAS:528:DyaK2cXlt1Kju7k%3D
26. T Yamamoto N Suto T Okubo A Mikuniya H Hanada S Yaguihashi M Fujita K Okumura 2001 Intramyocardial delivery of basic fibroblast growth factor-impregnated gelatin hydrogel microspheres enhances collateral circulation to infracted canine myocardium Jpn Circ J 65 439-444 11348050 10.1253/jcj.65.439 1:CAS:528:DC%2BD3MXjs1SksbY%3D
27. R Jarvik S Westaby T Katsumata D Piqott RD Evans 1998 LVAD power delivery: A percutaneous approach to avoid infection Ann Thorac Surg 65 470-473 9485248 10.1016/S0003-4975(97)01343-X 1:STN:280:DyaK1c7ktlOqsg%3D%3D